Alder BioPharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares
June 30, 2015 at 16:01 PM EDT
Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a clinical-stage biopharmaceutical company, announced today that the underwriters of its ...